Mechanochemistry towards greener pharmaceuticals
Innovative processes to revolutionise how we manufacture drugs and chemicals
Greener pharma
The pharmaceutical industry generates tons of toxic waste and carbon emissions. Moreover, it often relies on the supply chains of chemicals and catalysts, which limits timely production during emergencies.
Mechano…what?
Mechanochemistry gets rid of solvents. It uses mechanical force, like grinding and milling, to drive chemical reactions. It’s succesfully used by other industrial sectors (aerospace, cosmetics, fertilisers…). Now, IMPACTIVE will validate its use in pharma.
An impactful solution
IMPACTIVE is a project funded by the European Commission, which counts on 17 partners in 10 different countries. Our expertise covers the whole value chain, from research to industry and innovation, which will ensure our solutions find ways to market.
Strong industrial collaboration
IMPACTIVE counts with the industry from the start. 2 international companies (Merck & Novartis) are part of the project, to help with the scaling up.
News
+ Go to news page
Prepare for our upcoming webinar on assessing risk and impurities in mechanochemical synthesis
Join us on our ninth webinar session for a lively discussion with our researchers Dzmitry Kananovich and Riina Aav, from Tallinn University of Technology. Save the date: it will take place on Wednesday, 17 June at 16:00 CEST.
Discover the challenges in scaling up mechanochemical reactions in our upcoming webinar
Join us on our eighth webinar session for a lively discussion with our researcher Michael Felderhoff, from the Max-Planck-Institut für Kohlenforschung. We’ll talk about ball mills and how to use them to scale up mechanochemical transformations from milligrams to kilograms. Save the date: it will take place on Thursday, 28 May at 16:00 CEST.
Meet HES-SO, our partner behind large-scale reactions
Scaling up from milligrams to kilograms is no easy task, but our Swiss partner has what it takes: the Dyno®-Mill, a specific type of bead mill that complements the abilities and resources of the rest of the consortium.